Praxis Precision Medicines (PRAX) Short Interest Ratio & Short Volume $37.64 +0.44 (+1.18%) Closing price 04/30/2025 04:00 PM EasternExtended Trading$37.03 -0.61 (-1.62%) As of 09:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Praxis Precision Medicines Short Interest DataPraxis Precision Medicines (PRAX) has a short interest of 1.85 million shares, representing 9.87% of the float (the number of shares available for trading by the public). This marks a -7.04% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 381,640 shares to cover all short positions.Current Short Interest1,850,000 sharesPrevious Short Interest1,990,000 sharesChange Vs. Previous Month-7.04%Dollar Volume Sold Short$54.89 millionShort Interest Ratio3.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares20,163,000 sharesFloat Size18,740,000 sharesShort Percent of Float9.87%Today's Trading Volume589,431 sharesAverage Trading Volume381,640 sharesToday's Volume Vs. Average154% Short Selling Praxis Precision Medicines? Sign up to receive the latest short interest report for Praxis Precision Medicines and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPRAX Short Interest Over TimePRAX Days to Cover Over TimePRAX Percentage of Float Shorted Over Time Praxis Precision Medicines Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20251,850,000 shares $54.89 million -7.0%9.9%3.5 $29.67 3/31/20251,990,000 shares $75.36 million -3.4%10.6%3.9 $37.87 3/15/20252,060,000 shares $78.86 million +13.2%11.0%4.5 $38.28 2/28/20251,820,000 shares $70.25 million -31.8%9.7%4 $38.60 2/15/20252,670,000 shares $242.36 million +1.9%15.5%7.3 $90.77 1/31/20252,620,000 shares $200.56 million +28.4%15.2%6.9 $76.55 1/15/20252,040,000 shares $141.96 million +7.4%11.8%5.9 $69.59 12/31/20241,900,000 shares $146.22 million +24.2%11.0%5.8 $76.96 12/15/20241,530,000 shares $107.38 million +4.1%8.8%4.6 $70.18 11/30/20241,470,000 shares $117.85 million -3.9%8.5%5 $80.17 Get the Latest News and Ratings for PRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Praxis Precision Medicines and its competitors with MarketBeat's FREE daily newsletter. 11/15/20241,530,000 shares $109.79 million -11.1%8.9%4.9 $71.76 10/31/20241,720,000 shares $120.38 million No Change10.0%6.2 $69.99 10/15/20241,720,000 shares $123.93 million -4.4%10.5%6.7 $72.05 9/30/20241,800,000 shares $103.57 million -5.3%11.0%6.8 $57.54 9/15/20241,900,000 shares $113.77 million -2.1%11.6%5.9 $59.88 8/31/20241,940,000 shares $103.11 million +4.3%11.8%5.5 $53.15 8/15/20241,860,000 shares $101.37 million -1.6%11.4%5.2 $54.50 7/31/20241,890,000 shares $109.07 million +18.9%12.4%5.1 $57.71 7/15/20241,590,000 shares $81.06 million +12.8%10.4%4.3 $50.98 6/30/20241,410,000 shares $58.32 million +63.0%9.2%4 $41.36 6/15/2024865,300 shares $33.72 million +23.2%5.7%2.6 $38.97 5/31/2024702,200 shares $33.33 million -16.9%4.6%2.5 $47.46 5/15/2024844,900 shares $37.18 million +2.5%5.5%3.4 $44.00 4/30/2024824,400 shares $45.23 million +7.9%5.1%4 $54.87 4/15/2024763,900 shares $40.78 million +77.1%4.7%3.8 $53.39 3/31/2024431,400 shares $26.32 million +5.4%2.7%2 $61.02 3/15/2024409,400 shares $22.57 million -1.3%3.3%2.4 $55.14 2/29/2024414,800 shares $19.40 million +18.9%3.3%2.8 $46.78 2/15/2024348,900 shares $14.42 million -38.1%4.3%2.5 $41.34 1/31/2024564,000 shares $24.61 million +15.9%7.1%4.5 $43.63 1/15/2024486,700 shares $21.11 million +31.2%6.1%4.4 $43.37 12/31/2023371,000 shares $8.27 million +57.5%4.8%5.1 $22.28 12/15/2023235,500 shares $3.64 million +18.5%3.0%4.3 $15.46 11/30/2023198,700 shares $3.62 million -94.3%2.6%4.1 $18.20 11/15/20233,460,000 shares $3.36 million +25.4%N/A4.7 $0.97 10/31/20232,760,000 shares $2.84 million -11.0%N/A2.8 $1.03 10/15/20233,100,000 shares $4.22 million -1.6%N/A3.1 $1.36 9/30/20233,150,000 shares $5.39 million +27.0%N/A3.2 $1.71 9/15/20232,480,000 shares $3.45 million -8.8%N/A2.3 $1.39 8/31/20232,720,000 shares $4.00 million +10.6%N/A2.3 $1.47Massive new energy source found in Utah (Ad)NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.Find out what billionaires already know about this new energy source 8/15/20232,460,000 shares $2.76 million -16.6%N/A2.1 $1.12 7/31/20232,950,000 shares $2.92 million +13.0%N/A3 $0.99 7/15/20232,610,000 shares $3.00 million -12.1%N/A2.6 $1.15 6/30/20232,970,000 shares $3.42 million -35.2%N/A2.9 $1.15 6/15/20234,580,000 shares $4.14 million +3.9%N/A4.4 $0.91 5/31/20234,410,000 shares $3.79 million -14.0%N/A4.6 $0.86 5/15/20235,130,000 shares $5.54 million +2.4%N/A3.2 $1.08 4/30/20235,010,000 shares $5.21 million -3.3%N/A3.2 $1.04 4/15/20235,180,000 shares $5.18 million -13.2%12.5%3 $1.00 3/31/20235,970,000 shares $4.83 million +34.2%14.4%3 $0.81 3/15/20234,450,000 shares $5.07 million +37.8%10.7%2.3 $1.14 2/28/20233,230,000 shares $9.90 million +2.2%7.4%1.9 $3.07 2/15/20233,160,000 shares $11.69 million +17.9%7.3%3.2 $3.70 1/31/20232,680,000 shares $13.35 million +25.2%6.9%2.8 $4.98 1/15/20232,140,000 shares $7.62 million +0.5%5.5%2.5 $3.56 12/30/20222,130,000 shares $5.07 million +11.5%5.5%4.6 $2.38 12/15/20221,910,000 shares $4.68 million +3.8%4.9%4.3 $2.45 11/30/20221,840,000 shares $4.07 million -1.1%4.8%2.9 $2.21 11/15/20221,860,000 shares $3.98 million -11.4%4.8%2.7 $2.14 10/31/20222,100,000 shares $4.14 million +1.9%5.6%2.8 $1.97 10/15/20222,060,000 shares $3.44 million +0.5%5.5%2.7 $1.67 9/30/20222,050,000 shares $4.65 million -39.7%5.5%2.6 $2.27 9/15/20223,400,000 shares $9.72 million +5.9%9.1%3.4 $2.86 8/31/20223,210,000 shares $10.02 million +7.0%8.6%2.8 $3.12 8/15/20223,000,000 shares $13.98 million -18.3%8.1%1.7 $4.66 7/31/20223,670,000 shares $12.96 million -1.6%9.9%2 $3.53 7/15/20223,730,000 shares $13.35 million +3.6%10.1%2.1 $3.58 6/30/20223,600,000 shares $8.82 million +25.0%9.7%2.2 $2.45 6/15/20222,880,000 shares $5.56 million -29.8%7.8%1.9 $1.93 5/31/20224,100,000 shares $34.03 million +7.9%11.1%3.7 $8.30 5/15/20223,800,000 shares $39.33 million +6.7%10.3%12.5 $10.35 4/30/20223,560,000 shares $28.84 million +11.6%9.6%14.6 $8.10 4/15/20223,190,000 shares $27.56 million +2.9%8.6%14.2 $8.64 3/31/20223,100,000 shares $31.65 million -3.1%8.4%14.7 $10.21 3/15/20223,200,000 shares $33.76 million +17.2%8.7%15.3 $10.55 2/28/20222,730,000 shares $35.76 million +14.2%7.4%11 $13.10 2/15/20222,390,000 shares $32.38 million +18.9%6.6%8.9 $13.55 1/31/20222,010,000 shares $29.87 million +10.4%5.4%7.4 $14.86 1/15/20221,820,000 shares $31.90 million No Change4.9%7 $17.53 12/31/20211,820,000 shares $35.85 million +21.3%4.9%7.4 $19.70 12/15/20211,500,000 shares $27.81 million +1.4%4.0%6 $18.54 11/30/20211,480,000 shares $25.32 million -3.9%4.0%6.1 $17.11 11/15/20211,540,000 shares $29.75 million +5.5%4.1%6.9 $19.32 10/29/20211,460,000 shares $30.37 million +2.8%4.0%6.1 $20.80 10/15/20211,420,000 shares $28.41 million -12.4%3.9%6.1 $20.01 9/30/20211,620,000 shares $29.95 million +19.1%4.5%6.9 $18.49 9/15/20211,360,000 shares $26.81 million +12.4%3.8%4.9 $19.71 8/31/20211,210,000 shares $24.04 million -6.2%3.4%4.1 $19.87 8/13/20211,290,000 shares $17.80 million -9.2%3.9%4.1 $13.80 7/30/20211,420,000 shares $22.15 million +10.1%4.5%3.4 $15.60Massive new energy source found in Utah (Ad)NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millions of years. And both grizzled oilmen and clean energy supporters love it: Energy Secretary Chris Wright called it "an awesome resource," while Warren Buffett, Jeff Bezos, Mark Zuckerberg, and Bill Gates are all directly invested.Find out what billionaires already know about this new energy source 7/15/20211,290,000 shares $22.20 million +2.4%4.1%3 $17.21 6/30/20211,260,000 shares $23.03 million -13.7%4.4%2.8 $18.28 6/15/20211,460,000 shares $29.46 million +13.2%5.0%3.6 $20.18 5/28/20211,290,000 shares $25.27 million -19.4%4.5%3.4 $19.59 5/14/20211,600,000 shares $30.03 million -13.5%5.5%4.8 $18.77 4/30/20211,850,000 shares $59.61 million -18.1%7.2%10.2 $32.22 4/15/20212,260,000 shares $57.18 million +11.9%9.4%14 $25.30 3/31/20212,020,000 shares $59.27 million +129.1%8.4%14.3 $29.34 3/15/2021881,700 shares $39.06 million +9.4%3.7%4.2 $44.30 2/26/2021805,900 shares $36.57 million -9.7%3.4%3.9 $45.38 2/12/2021892,700 shares $46.78 million -35.3%5.5%4.1 $52.40 1/29/20211,380,000 shares $71.61 million -22.0%5.7%5.2 $51.89 1/15/20211,770,000 shares $105.88 million No Change7.4%6.4 $59.82 PRAX Short Interest - Frequently Asked Questions What is Praxis Precision Medicines' current short interest? Short interest is the volume of Praxis Precision Medicines shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,850,000 shares of PRAX short. 9.87% of Praxis Precision Medicines' shares are currently sold short. Learn More on Praxis Precision Medicines' current short interest. What is a good short interest ratio for Praxis Precision Medicines? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRAX shares currently have a short interest ratio of 4.0. Learn More on Praxis Precision Medicines's short interest ratio. Which institutional investors are shorting Praxis Precision Medicines? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Praxis Precision Medicines: Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., and Barclays PLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Praxis Precision Medicines? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.87% of Praxis Precision Medicines' floating shares are currently sold short. Is Praxis Precision Medicines' short interest increasing or decreasing? Praxis Precision Medicines saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 1,850,000 shares, a decline of 7.0% from the previous total of 1,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Praxis Precision Medicines' float size? Praxis Precision Medicines currently has issued a total of 20,163,000 shares. Some of Praxis Precision Medicines' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Praxis Precision Medicines currently has a public float of 18,740,000 shares. How does Praxis Precision Medicines' short interest compare to its competitors? 9.87% of Praxis Precision Medicines' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Praxis Precision Medicines: Viking Therapeutics, Inc. (23.97%), Xenon Pharmaceuticals Inc. (5.51%), Catalyst Pharmaceuticals, Inc. (7.34%), Protagonist Therapeutics, Inc. (9.88%), HUTCHMED (China) Limited (0.30%), Immunovant, Inc. (30.49%), MoonLake Immunotherapeutics (12.52%), ACADIA Pharmaceuticals Inc. (12.84%), Alvotech (0.73%), Twist Bioscience Co. (16.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Praxis Precision Medicines stock? Short selling PRAX is an investing strategy that aims to generate trading profit from Praxis Precision Medicines as its price is falling. PRAX shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Praxis Precision Medicines? A short squeeze for Praxis Precision Medicines occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRAX, which in turn drives the price of the stock up even further. How often is Praxis Precision Medicines' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRAX, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Viking Therapeutics Short Interest Data Xenon Pharmaceuticals Short Interest Data Catalyst Pharmaceuticals Short Interest Data Protagonist Therapeutics Short Interest Data HUTCHMED Short Interest Data Immunovant Short Interest Data MoonLake Immunotherapeutics Short Interest Data ACADIA Pharmaceuticals Short Interest Data Alvotech Short Interest Data Twist Bioscience Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRAX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRAX Stock Free PRAX Stock Alerts